
Speciality Medicines
Open Date
Mar 20, 2026
Close Date
Mar 24, 2026
Min Investment
₹2,48,000
Lot Size
1000 Shares
Issue Size
₹29.14 Cr
Price Range
₹117 - ₹117
Listing Date
Mar 30, 2026
IPO Doc
RHP PDFAbout Speciality Medicines
Incorporated in the year 2021, Speciality Medicines Limited is a company involved in the marketing and distribution of finished formulations of speciality medicines across domestic and international markets. The company’s product portfolio includes a wide range of speciality pharmaceutical finished formulations products in various dosage forms, including tablets, capsules, creams, syrups, eye drops, gels, infusions, inhalers, injections, nasal sprays, ointments, ophthalmic solutions, oral solutions, sachets, and suspensions. The company operates in the following ways: contract manufacturing of finished formulations for international markets and marketing and distribution of sourced specialty pharmaceutical products. The company has expanded to the international market with registered/pending products in countries like Jordan, Ethiopia, Uganda, Peru, and Namibia. The company’s distribution network has established strong relationships with over 20 states in India and over 35 countries worldwide. As of March 31, 2025, the company has 1 product registered overseas and 60 products in the registration process across 5 countries, generating revenue. As of August 31, 2025, the company had a total of 18 permanent employees in various departments.
Checklist Quality Analysis
Revenue Growth
Company Valuation
Earning Expansion
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.
Speciality Medicines IPO - Issue Objectives
The company will utilise ₹12.68 crore for setting up an R&D center at Valsad, Gujarat. ₹2.99 crore will fund global product registration and development. The company will use ₹1.65 crore to fund its marketing and promotional activities. The company will utilise ₹8 crore for funding the working capital of the business. Part of the IPO proceeds will be used for general corporate purposes and issue expenses
Set up of R&D center
43.72%
Product registration and development
10.31%
Marketing expenses
5.72%
Working capital
27.59%
General corporate purposes
12.63%
Set up of R&D center
The company will utilise ₹12.68 crore for setting up an R&D center at Valsad, Gujarat.
Product registration and development
₹2.99 crore will fund global product registration and development.
Marketing expenses
The company will use ₹1.65 crore to fund its marketing and promotional activities.
Working capital
The company will utilise ₹8 crore for funding the working capital of the business.
General corporate purposes
Part of the IPO proceeds will be used for general corporate purposes and issue expenses
IPO Subscription Status
Financials of Speciality Medicines
In Cr.
Revenue: ₹36.93
EBITDA: ₹6.51
Profit: ₹6.06
| Key Performance Indicator | 31-Oct-25 (In Cr.) | 31-Mar-25 (In Cr.) | 31-Mar-24 (In Cr.) |
|---|---|---|---|
| Revenue | 36.93 | 58.54 | 27.66 |
| EBITDA | 6.51 | 9.09 | 5.26 |
| Expenses | |||
| Profit After Tax | 6.06 | 8.61 | 2.93 |
| Assets | 45.57 | 39.98 | 22.68 |
| Net Worth | 36.47 | 30.42 | 15.06 |
| Reserves | 30.04 | 23.98 | 9.95 |
| Borrowing | 4.81 | 5.05 | 2.86 |
Speciality Medicines - Promoter(s)
Parth B Goyani
Goyani Sumit Babubhai
59.28%
43.44%
Contact Details
Speciality Medicines
913, One World West, S. No. 396, FP 119, Village - Vejalpur, Ahmadabad City, Ahmedabad, Gujarat, India - 380051.
Registrar Contact Details
Speciality Medicines IPO - FAQs
Live IPOs
CMR Green Technologies
Vahh Chemicals
UHM Vacation
| Companies Name | Open - Close | Issue Size | Min. Qty | Issue Price | Apply |
|---|---|---|---|---|---|
CMR Green Technologies Mainboard BSE NSE | 3rd Jun 2026 - 5th Jun 2026 | 630.88 Cr | 78 Shares | ₹ 182.00 | |
Vahh Chemicals SME | 4th Jun 2026 - 8th Jun 2026 | 13.45 Cr | 2000 Shares | ₹ 60.00 | |
UHM Vacation SME | 4th Jun 2026 - 8th Jun 2026 | 36.02 Cr | 800 Shares | ₹ 157.00 | |
Hexagon Nutrition Mainboard | 5th Jun 2026 - 9th Jun 2026 | 138.87 Cr | 333 Shares | ₹ 42.00 |